In comparison, an increasing trend was observed in the number of CTCs captured from patients with metastatic cancer using anti-EpCAM antibodies.
← all excerpts
AFM-compatible microfluidic platform for affinity-based capture and nanomechanical characterization of circulating tumor cells.
1
—
—